We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

Memic raises $96 million to commercialize FDA approved robotic arm

12 4 1
13.04.2021

Memic Innovative Surgery, a medical device company, said it has closed a $96 million Series D funding round, led by Israel’s Peregrine Ventures and investment firm Ceros. along with Jerusalem’s OurCrowd and Israeli VC Accelmed.

The money raised will help commercialize the startup’s Hominis robotic-assisted surgical platform in the US and potentially other countries around the world, the company said in a statement.

The Hominis Surgical System developed by Memic features miniature humanoid-shaped robotic arms. Last month the firm said it received marketing authorization from the US Food and Drug Administration for the robotic surgical device to perform transvaginal hysterectomies in patients.

Get The Start-Up Israel's Daily Start-Up by email and never miss our top stories Free Sign Up

The device is intended for benign hysterectomy, or the removal of the uterus for non-cancerous conditions along with the removal of one or both fallopian tubes and ovaries. The........

© The Times of Israel


Get it on Google Play